Abstract
摘要
相似文献
1
Copayments dominate drug cost sharing choices.自付费用在药物费用分担选择中占主导地位。
Manag Care. 2012 Nov;21(11):55.
2
Financial incentives and drug spending in managed care.
LDI Issue Brief. 1999 May;4(1):1-4.
3
Patient cost sharing: how much is too much?患者费用分担：多少才算过多？
Issue Brief Cent Stud Health Syst Change. 2003 Dec(72):1-4.
4
Rising out-of-pocket costs in disease management programs.疾病管理项目中自付费用的不断增加。
Am J Manag Care. 2006 Mar;12(3):150-4.
5
Stats & facts. More consumer cost sharing in pharmacy benefit.统计数据与事实。药房福利中消费者需承担更多费用分摊。
Manag Care Interface. 2002 Apr;15(4):34-5.
6
Plans continue to raise copayments.提高自付费用的计划仍在继续。
Manag Care. 2005 Sep;14(9):59.
7
Insurers offer more coverage to fill Part D gap.保险公司提供更多保险范围以填补D部分的缺口。
Manag Care. 2007 Dec;16(12):54.
8
Medicaid copayments.医疗补助自付费用
Issue Brief Health Policy Track Serv. 2012 Jan 3:1-8.
9
Average out-of-pocket health care costs for Medicare+Choice enrollees increase substantially in 2002.2002年，医疗保险+选择计划参保人的平均自付医疗保健费用大幅增加。
Issue Brief (Commonw Fund). 2002 Nov(575):1-8.
10
The future of prescription drug cost-sharing: real progress or dropped opportunity?处方药费用分摊的未来：是真正的进展还是错失的机遇？
J Manag Care Pharm. 2008 Jan-Feb;14(1):70-82. doi: 10.18553/jmcp.2008.14.1.70.
Zotero 插件